THU284 BCG Clinical Trial Programs In Advanced Type 1 Diabetes - 2023 Update

Disclosure: W.M. Kühtreiber: None. E. Hostetter: None. A.H. Lee: None. N. Ng: None. G. Wolfe: None. A. Aristarkhova: None. J. Braley: None. H. Zheng: None. D.L. Faustman: None. The bacillus Calmette-Guerin (BCG) vaccine, first introduced a century ago for tuberculosis prevention, is today being test...

Descripción completa

Detalles Bibliográficos
Autores principales: Kühtreiber, Willem M, Hostetter, Emma, Lee, Amanda H, Ng, Nathan, Wolfe, Grace, Aristarkhova, Anna, Braley, Joan, Zheng, Hui, Faustman, Denise L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553735/
http://dx.doi.org/10.1210/jendso/bvad114.720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553735/
http://dx.doi.org/10.1210/jendso/bvad114.720

Ejemplares similares